Picture of Pulmonx logo

LUNG — Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Pulmonx Corp expected to post a loss of 28 cents a share - Earnings Preview

Pulmonx Corp <LUNG.OQ> expected to post a loss of 28 cents a share - Earnings Preview 
  • Pulmonx Corp LUNG.OQ LUNG.O is expected to show a fall in quarterly revenue when it reports results on July 29 for the period ending June 30 2026

  • The Redwood City California-based company is expected to report a 6.1% decrease in revenue to $22.4 million from $23.86 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Pulmonx Corp is for a loss of 28 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Pulmonx Corp is $3.00, about 156.4% above its last closing price of $1.17

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2026

-0.33

-0.33

-0.33

Met

-1

Dec. 31 2026

-0.39

-0.39

-0.25

Beat

36.2

Sep. 30 2025

-0.42

-0.42

-0.34

Beat

18.7​

Jun. 30 2025

-0.40

-0.37

-0.38

Missed

-1.8

​​Mar. 31 2025

-0.39

-0.37

-0.36

Beat

3.4

Dec. 31 2024

-0.44

-0.45

-0.33

Beat

26.3​

Sep. 30 2024

-0.45

-0.45

-0.36

Beat

19.7

Jun. 30 2024

-0.42

-0.43

-0.35

Beat

17.7

This summary was machine generated July 27 at 21:09 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Pulmonx

See all news